A research team has made a breakthrough in epigenetic drug discovery. The researchers have successfully developed a ...

Pancreatic cancer is a rare disease; however, its initially inconspicuous symptoms and aggressive nature make it one of the ...

Scientists at Duke-NUS Medical School and the National University Health System (NUHS), together with an international team ...

Patients with severe melanoma who received the treatment were 49% less likely to die or have their cancer return, ...

A vitamin A byproduct has been found to quietly disarm the immune system, allowing tumors to evade attack and weakening ...

Eating more anti-inflammatory and antioxidant-rich foods may slow biological aging and help reduce the risk of skin cancer, according to a study published in Cancers.1 ...

Gene that drops early in pancreatic tumors linked to shorter survival at stage II. Findings could guide future treatment ...

The investigational cancer vaccine, NOUS-209, was found to safely stimulate the immune system to target precancerous and ...

BostonGene, a leader in AI-powered solutions for drug discovery and development, is transforming how pharmaceutical companies develop, target, and deliver cancer therapies — making precision medicine ...

In a novel use of the CRISPR/Cas9 system, which can be deployed to switch genes off, researchers from Germany, the UK and Spain have developed a multiplexed screening approach to study and model ...

Multiple preservatives that are added to food products to lengthen their shelf life have significant associations with overall cancer development.